Cannabis capitalists: the business leaders hoping for a marijuana boom

The 2016 Election And The Marijuana Vote | MSNBC

Marijuana Sector Remains One of Markets Hottest Industry Behind Newest Products and Services

PALM BEACH, Florida, November 16, 2016 /PRNewswire/ --

The exploding cannabis and legal marijuana industry, globally and within the United States, is calling for a significant expansion and improvement of both services and operations as marijuana stocks within the industry aim to capitalize on the unprecedented momentum. Active companies in the sector this week include: Vemanti Group, Inc. (OTC: VMNT), Medical Marijuana, Inc. (OTC: MJNA), Agritek Holdings, Inc. (OTC: AGTK), Cannabix Technologies Inc. (OTC: BLOZF) and Medical Cannabis Payment Solutions (OTC: REFG).

Vemanti Group, Inc. (OTC PINK: VMNT) a diversified holding corporation, announced today that its preparing to launch a new wholly-owned subsidiary, which will look to provide a comprehensive mobile commerce and payments service for the emerging cannabis industry. Through their smartphones, the service will enable retail customers to pay for goods at any participating dispensary without using physical cash. It will also present dispensaries, growers, and other legitimate participants of the industry with the opportunity of carrying out non-retail transactions among themselves in digital payments. 

Read the full Vemanti (VMNT) Press Release at: http://marketnewsupdates.com/news/vmnt.html

The Company believes that the emerging legal cannabis industry where retail and non-retail transactions, including vendor payments and payroll, are almost exclusively paid for with cash presents a real challenge for financial institutions. Concerned about the evolving conflict between federal and state laws, they are eager to avoid the inherent risks associated with this cash-intensive sector. It is widely acknowledged that many are unwilling to go to the expense of establishing and maintaining the type of thorough due diligence program for this emerging market at the present time in order to comply with growing demands of Know-Your-Customer (KYC) guidelines, anti-money laundering regulations, and the US Patriot Act. As the result, traditional banking and payment solutions have been out of reach for the vast majority of cannabis businesses.

"The cannabis industry needs access to digital payments in order to grow, and consumers want a safe and secure way to purchase marijuana products without always relying on cash. Our goal for the new subsidiary is to launch a service that alleviates the risk of cash transactions and helps dispensaries monitor and record data needed to address concerns about violating anti-money laundering laws, with the long-term goal of moving transactions away from cash altogether. It will comply with every relevant regulatory requirement and provide a sustainable solution for the cannabis industry", commented Tan Tran, CEO of Vemanti Group.

In other cannabis developments and happenings to watch this week in the markets:

StoneBridge Partners, LLC -- a global finance communication and consulting firm -- announces the release of an in-depth business analysis of Medical Marijuana, Inc. (OTC PINK: MJNA) presented in a comprehensive report. The report, which outlines the company's formation and current operations, also offers insight into the perceived opportunities in the explosive-growth market of cannabis. It explores the Company's diversified portfolio of cannabis organizations and brands that continue to flourish as new markets open and existing markets continue to develop

Agritek Holdings, Inc. (OTC: AGTK) closed down slightly on Tuesday on just over 6.88 Million shares traded by the market close. Agritek Holdings, Inc. offers various products and services to the medicinal marijuana sector in the United States. It distributes hemp-based nutritional products; and provides solutions for electronically processing merchant transactions.

Cannabix Technologies Inc. (OTC Pink: BLOZF) closed up over 24% on Tuesday at $0.59 on just under 1 Million shares traded by the market close. Cannabix Technologies, developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, recently released images of its Beta 2.0 Cannabix Marijuana Breathalyzer. New images of the device can be viewed at http://www.cannabixtechnologies.com.

Medical Cannabis Payment Solutions (OTC: Pink: REFG) works to solve the fragmentation problem by identifying tools that are important to dispensaries, and customizing those tools specifically catered to the industry. We strive to create awareness within the medicinal marijuana industry and to develop an environmentally friendly, economically sustainable business while increasing shareholder value.

DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Vemanti Group, Inc.. by the company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:
Media Contact email: info@marketnewsupdates.com - +1-(561)325-8757

SOURCE MarketNewsUpdates.com
Marijuana Sector Remains One of Markets Hottest Industry Behind Newest Products and Services

U.S. Patent Allowance Granted to Medical Marijuana, Inc.'s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

SAN DIEGO, CA--(Marketwired - November 16, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its major investment AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM), a world leader in hemp cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 9,433,601, a patent that claims the use of all cannabinoids in cannabinoid-containing controlled-release chewing gum products. A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from the application, filed in April 2015. This patent covers the inclusion of all cannabinoids (both natural and synthetic) in a chewing gum delivery system, including Tetrahydrocannabinol (THC), all of which may be incorporated in the Company's chewing gum products.

This new patent is an extension of AXIM® Biotech's patent for chewing gum as delivery methods for cannabidiol (Chewing Gum Compositions Comprising Cannabinoids). Prior to this new allowance, Patent 9,023,322 only claimed gum products as a delivery mechanism for cannabidiol (CBD), a well-known cannabinoid.

"We congratulate the AXIM team on receiving this new patent, another major milestone in the Company's continued efforts to research new solutions using cannabinoid-based drugs," said Dr. Stuart Titus, CEO of Medical Marijuana, Inc.

"This patent will enable AXIM to include any of the at least 85 different cannabinoid compounds found in the cannabis plant, including CBD and THC, into its multiple cannabinoid controlled-release chewing gum products," added Dr. Titus. "As investors in AXIM, we are enthusiastic about how the Company continues to move forward as a leader in cannabinoid research and development."

AXIM® Biotech developed the patents it now owns for chewing gum as a delivery method for cannabinoids into two separate products. Its CBD-only Canchew® gum is marketed and is legal to purchase wherever CBD hemp oil products are sold. AXIM® Biotech holds the exclusive rights to market and distribute CanChew® Gum globally. CanChew® is a botanical hemp-derived CBD chewing gum with a unique oral mucosal absorbance delivery system. Features listed on the CanChew® website include:

• Non-habit forming
• No prescription needed
• Available in all 50 states
• Great-tasting mint gum has no artificial sweeteners or preservatives
• Non-GMO, gluten free, vegan and kosher

In addition, AXIM® will start clinical trials for its combination CBD/THC gum, MedChew® Rx, for the treatment of pain and spasticity associated with multiple sclerosis. Directly compared to a sublingually delivered cannabis-based product currently on the market for MS, the estimated market size for MedChew® Rx is $4.8 billion USD. MedChew® Rx is on track to be fully registered by the EMA and FDA.

AXIM has also developed CanChew Plus™ CBD containing gum with improved delivery system and doses of 10 mg of CBD and 30mg of CBD which is set to begin clinical trials in the EU. Besides these, AXIM has developed CanChew Rx™, which is based on pharmaceutical-grade, 99.9% pure CBD crystals, extracted and manufactured based on company IPs and containing 10, 30, 50, 100 and 150 mg of CBD in microencapsulated form (AXIM IP) for significantly increased bioavailability of the Active Pharmaceutical Ingredient.

Another AXIM® Biotech patent-pending cannabis innovation in clinical trials is AX-1602. The first of its kind, AX-1602 contains CBG (cannabigerol) and other cannabinoids as a treatment for psoriasis and atopic dermatitis.

AXIM® Biotech's core belief is responsibility for environmental stewardship combined with development of innovative products to address conditions with no currently known effective treatment including: Parkinson's disease, Alzheimer's disease/dementia, ADHD(attention deficit hyperactivity disorder), PTSD, autism, MS, spasticity, pain, RLS (restless leg syndrome), glaucoma, IBD, IBS and Crohn's disease.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

U.S. Patent Allowance Granted to Medical Marijuana, Inc.'s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

Legalizzazione della cannabis, il senatore Della Vedova a Reggio Emilia

Appuntamento alle 17 di domenica 6 al circolo Gardenia in via Regina Elena. Si parlerà della proposta di legge ora in discussione in parlamento e di processi di regolarizzazione vincenti

REGGIO EMILIA - Questa estate a Reggio Emilia sono state raccolte 2.300 firme a supporto della legge popolare "legalizziamo"; lo scorso ottobre è stato approvato un documento in Consiglio comunale a favore della proposta in discussione in parlamento "cannabis legale", supportata da oltre 130 parlamentari.

I fatti dicono che negli ultimi decenni produzione, traffici e consumatori di stupefacenti sono cresciuti a dismisura, divenendo il terzo business più redditizio al mondo dopo cibo ed energia. Solo in Italia, il giro d’affari della narcomafie è stimato intorno ai 30 miliardi euro.

Delle effetto delle droghe non solo sulla nostra società, ma anche sulle democrazie nel mondo se ne parlerà domenica 6 novembre alle 17 al circolo Arci Gardenia, in viale Regina Elena 14: il Circolo Darwin e Canapaio Ducale Parma propongono un incontro aperto di approfondimento sul tema della legalizzazione della cannabis.

Per l'occasione sarà presente il senatore Benedetto Della Vedova, presidente dell’intergruppo Cannabis Legale, che presenterà la proposta di legge ora in discussione in parlamento; insieme a lui ci sarà anche Luca Marola di Canapaio Ducale, che parlerà di processi di legalizzazione vincenti realizzati nel mondo. Modera il dibattito Dario De Lucia, il consigliere comunale Pd che ha fatto approvare il documento a favore della vendita di Stato della marijuana.

Legalizzazione della cannabis, il senatore Della Vedova a Reggio Emilia